Paraspinal muscle vasculature contributes to posterolateral spinal fusion

Spine

Volumn 31, Issue 8, 2006, Pages 891-896

  Bawa, Maneesh ^a   Schimizzi, Aimee L ^a   Leek, Bryan ^a   Bono, Christopher M ^b   Massie, Jennifer B ^a,c   Macias, Brandon ^a   Chung, Christine B ^a   Hargens, Alan R ^a   Garfin, Steven R ^a   Kim, Choll W ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fusion; Paraspinal muscle; Posterolateral; Rabbit; Vascular

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BONE GRAFT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEALING; HISTOLOGY; MUSCLE BLOOD VESSEL; NONHUMAN; POROSITY; PRIORITY JOURNAL; RABBIT; SPINE FUSION; SPINE RADIOGRAPHY; SURGICAL TECHNIQUE; TIBIA;

ANIMALS; LUMBAR VERTEBRAE; MUSCLE, SKELETAL; RABBITS; SPINAL FUSION;

EID: 33646440730     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000209301.15262.56     Document Type: Article

References (37)

1. Boden SD. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 2000;6:383-99.
2. Steinmann JC, Herkowitz HN. Pseudarthrosis of the spine. Clin Orthop 1992;284:80-90.
3. DePalma AF, Rothman RH. The nature of pseudarthrosis. Clin Orthop 1968;284:113-8.
4. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
5. Feiertag MA, Boden SD, Schimandle JH, et al. A rabbit model for nonunion of lumbar intertransverse process spine arthrodesis. Spine 1996;21:27-31.
6. Grauer JN, Patel TC, Erulkar JS, et al. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2001;26:127-33.
7. Ishikawa S, Shin HD, Bowen JR, et al. Is it necessary to decorticate segmentally instrumented spines to achieve fusion? Spine 1994;19:1686-90.
8. Martin GJ Jr, Boden SD, Titus L. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine 1999;24:2188-93; discussion 2193-4.
9. Morone MA, Boden SD, Hair G, et al. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop Relat Res 1998;351:252-65.
10. Slappey G, Toribatake Y, Ganey TM, et al. Guidelines to decortication in posterolateral spine fusion. J Spinal Disord 1998;11:102-9.
11. Theiss SM, Boden SD, Hair G, et al. The effect of nicotine on gene expression during spine fusion. Spine 2000;25:2588-94.
12. Toribatake Y, Hutton WC, Tomita K, et al. Vascularization of the fusion mass in a posterolateral intertransverse process fusion. Spine 1998;23:1149-54.
13. Vaccaro AR, Chiba K, Heller JG, et al. Bone grafting alternatives in spinal surgery. Spine J 2002;2:206-15.
14. Boden SD, Schimandle JH. Biology of lumbar spine fusion and bone graft materials. In: International Society for Study of the Lumbar Spine Editorial Committee, ed. The Lumbar Spine, 2nd ed. Philadelphia: Saunders, 1996:1284-306.
15. Simon SR, ed. Orthopaedic Basic Science, 2nd ed. Rosemont, IL: AAOS, 1994.
16. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop Relat Res 1985;200:125-41.
17. Salama R, Weissman SL. The clinical use of combined xenografts of bone and autologous red marrow: a preliminary report. J Bone Joint Surg Br 1978;60:111-5.
18. Begley CT, Doherty MJ, Hankey DP, et al. The culture of human osteoblasts upon bone graft substitutes. Bone 1993;14:661-6.
19. Connolly JF, Guse R, Tiedeman J, et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991;266:259-70.
20. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2003;12:495-500.
21. Oikarinen J. Experimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbits. Clin Orthop Relat Res 1982;162:210-8.
22. Pals SD, Wilkins RM. Giant cell tumor of bone treated by curettage, cementation, and bone grafting. Orthopedics 1992;15:703-8.
23. Morone MA, Boden SD. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 1998;23:159-67.
24. Martin GJ Jr, Boden SD, Titus L, et al. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine 1999;24:637-45.
25. Muschler GF, Huber B, Ullman T, et al. Evaluation of bone-grafting materials in a new canine segmental spinal fusion model. J Orthop Res 1993;11:514-24.
26. Martin GJ Jr, Boden SD, Marone MA, et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 1999;12:179-86.
27. Hecht BP, Fischgrund JS, Herkowitz HN, et al. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 1999;24:629-36.
28. Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion: II: Study of dose, carrier, and species. Spine 1995;20:2633-44.
29. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
30. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
31. Cierny G 3rd, Byrd HS, Jones RE. Primary versus delayed soft tissue coverage for severe open tibial fractures: a comparison of results. Clin Orthop Relat Res 1983;178:54-63.
32. Sanderson C, Radley K, Mayton L. Ethylenediaminetetraacetic acid in ammonium hydroxide for reducing decalcification time. Biotech Histochem 1995;70:12-8.
33. Altner PC, Grana L, Gordon M. An experimental study on the significance of muscle tissue interposition on fracture healing. Clin Orthop 1975;111:269-73.
34. Lemperle SM, Calhoun CJ, Curran RW, et al. Bony healing of large cranial and mandibular defects protected from soft-tissue interposition: a comparative study of spontaneous bone regeneration, osteoconduction, and cancellous autografting in dogs. Plast Reconstr Surg 1998;101:660-72.
35. Pineda LM, Busing M, Meinig RP, et al. Bone regeneration with resorbable polymeric membranes: III. Effect of poly(L-lactide) membrane pore size on the bone healing process in large defects. J Biomed Mater Res 1996;31:385-94.
36. Poynton AR, Zheng F, Tomin E, et al. Resorbable posterolateral graft containment in a rabbit spinal fusion model. J Neurosurg 2002;97:460-3.
37. Hurley LA, Stinchfield FE, Bassett AL, et al. The role of soft tissues in osteogenesis: an experimental study of canine spine fusions. Am J Orthop 1959;41:1243-54.